Search for content, post, videos

AZ, Foundation Medicine enter strategic collaboration

AstraZeneca has entered into a definitive agreement with Foundation Medicine, Inc. (Foundation Medicine) to develop a novel companion diagnostic assay for Lynparza (olaparib) to support its global development programme. The companion diagnostic will enable physicians to identify those patients mo
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.